NRx Pharma

NRx Pharma The U.S.

We are NRx – a pioneering and focused CNS biopharma company, dedicated to meeting unmet medical needs for those with suicidal depression, suicidal bipolar depression, and post-traumatic stress disorder (PTSD). Food and Drug Administration (“FDA”) has additionally granted Breakthrough Therapy designation, a Special Protocol Agreement, and a Biomarker Letter of Support for NRX-101, an investigational medicine for the treatment of severe bipolar depression in patients with acute suicidal ideation and behavior (ASIB) after initial stabilization with ketamine or other effective therapy. NRx Pharmaceuticals is led by executives who have held leadership roles at Lilly, Pfizer, and Novartis as well as major investment banking institutions.

11/20/2025

New analyst report from H.C. Wainwright - Transformative Progress Across Pipeline and Commercial Operations; Reiterate Buy

Read Report -https://www.nrxpharma.com/wp-content/uploads/2025/11/Transformative-Progress-Across-Pipeline-and-Commercial-Opera.pdf

$NRXP

NRx Pharmaceuticals (NASDAQ: NRXP) Reports Q3 Results and Advances NRX-100 and NRX-101 Regulatory Programs -BenzingaRead...
11/19/2025

NRx Pharmaceuticals (NASDAQ: NRXP) Reports Q3 Results and Advances NRX-100 and NRX-101 Regulatory Programs -Benzinga

Read More - https://www.benzinga.com/content/48903742/nrx-pharmaceuticals-nasdaq-nrxp-reports-q3-results-and-advances-nrx-100-and-nrx-101-regulatory-progr

$NRXP

Austin, Texas, United States, November 17th, 2025, FinanceWireNRx Pharmaceuticals (NASDAQ:NRXP) reported third-quarter 2025 results and outlined progress across its clinical programs, noting its first revenue-generating

11/18/2025

New analyst report from D. Boral Capital - Q3 Results and Expands Clinical and Commercial Footprint

Read Report -https://www.nrxpharma.com/wp-content/uploads/2025/11/Q3-Results-and-Expands-Clinical-and-Commercial-Footprint.pdf

$NRXP

NRx Pharmaceuticals (NASDAQ: NRXP) to Report Q3 2025 Financial Results and Host Conference Call on Nov. 17 -Yahoo Financ...
11/14/2025

NRx Pharmaceuticals (NASDAQ: NRXP) to Report Q3 2025 Financial Results and Host Conference Call on Nov. 17 -Yahoo Finance

Read More - https://finance.yahoo.com/news/nrx-pharmaceuticals-nrxp-report-q3-204223286.html

$NRXP

LOS ANGELES, CA - November 13, 2025 (NEWMEDIAWIRE) - NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, announced it will release its third quarter 2025 financial results before market open on Monday, Nov. 17, 2025, follo...

NRx Pharmaceuticals (NRXP) Launches HOPE Therapeutics' One-Day TMS Protocol for Treatment-Resistant Depression in Florid...
11/13/2025

NRx Pharmaceuticals (NRXP) Launches HOPE Therapeutics' One-Day TMS Protocol for Treatment-Resistant Depression in Florida -Yahoo Finance

Read More - https://finance.yahoo.com/news/nrx-pharmaceuticals-nrxp-launches-hope-201500589.html

$NRXP

LOS ANGELES, CA - November 10, 2025 (NEWMEDIAWIRE) - NRx Pharmaceuticals (NASDAQ: NRXP), announced that its subsidiary, HOPE Therapeutics(TM), has initiated patient care using the Ampa "one day" (ONE-D) protocol for treatment-resistant depression - t...

Today, we honor the brave men and women who have worn our nation’s uniform those who stood the watch, carried the burden...
11/11/2025

Today, we honor the brave men and women who have worn our nation’s uniform those who stood the watch, carried the burden, and protected the freedoms we hold dear.

At NRx Pharmaceuticals and Hope Therapeutics, Veterans Day is more than a date on the calendar. It is a reminder of our responsibility to stand with those who have served, especially as so many struggle with the invisible wounds of war.

Every day, our teams work to advance lifesaving treatments, expand access to mental-health innovation, and support the families who carry the weight of service alongside their loved ones.

This includes:
✅ Developing therapies focused on acute mental-health crises
✅ Supporting veteran-focused advocacy initiatives and community programs
✅ Partnering with organizations dedicated to su***de prevention and frontline resilience
✅ Elevating the voices of veterans, caregivers, clinicians, and community leaders

Our mission is rooted in a simple truth: those who served our nation deserve hope, healing, and a future they can believe in.

To all veterans' past, present, and those still serving thank you.

We are honored to stand with you today and every day. https://NRxPharma.com

New analyst report from D. Boral Capital - HOPE Therapeutics (NRXP) Executes Florida Roll-out of Ampa ONE-Day (ONE-D) Pr...
11/10/2025

New analyst report from D. Boral Capital - HOPE Therapeutics (NRXP) Executes Florida Roll-out of Ampa ONE-Day (ONE-D) Protocol for Treatment-Resistant Depression

Read Report - https://ir.nrxpharma.com/analyst-coverage

$NRXP

Address

1201 N Market Street, Suite 111
Wilmington, DE
19801

Alerts

Be the first to know and let us send you an email when NRx Pharma posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to NRx Pharma:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram